ConvaTec Group PLC - ESG Rating & Company Profile powered by AI
The page contains a zero-cost E,S&G assessment covering ConvaTec Group PLC. This Disclosure rating covers 17 UN SDGs including: 'Gender Equality', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. Comprehensive ESG assessment of ConvaTec Group PLC are reached by signing in.
ConvaTec Group PLC in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 7.6; made up of an environmental score of 8.0, social score of 6.9 and governance score of 8.0.
7.6
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
35 | DENTSPLY SIRONA Inc | 7.7 | High |
35 | Smith & Nephew PLC | 7.7 | High |
37 | ConvaTec Group PLC | 7.6 | High |
37 | Glaukos Corp | 7.6 | High |
37 | Hill-Rom Holdings Inc | 7.6 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does ConvaTec Group PLC have an accelerator or VC vehicle to help deliver innovation?
Does ConvaTec Group PLC disclose current and historical energy intensity?
Does ConvaTec Group PLC report the average age of the workforce?
Does ConvaTec Group PLC reference operational or capital allocation in relation to climate change?
Does ConvaTec Group PLC disclose its ethnicity pay gap?
Does ConvaTec Group PLC disclose cybersecurity risks?
Does ConvaTec Group PLC offer flexible work?
Does ConvaTec Group PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does ConvaTec Group PLC disclose the number of employees in R&D functions?
Does ConvaTec Group PLC conduct supply chain audits?
Does ConvaTec Group PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does ConvaTec Group PLC conduct 360 degree staff reviews?
Does ConvaTec Group PLC disclose the individual responsible for D&I?
Does ConvaTec Group PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does ConvaTec Group PLC disclose current and / or historical scope 2 emissions?
Does ConvaTec Group PLC disclose water use targets?
Does ConvaTec Group PLC have careers partnerships with academic institutions?
Did ConvaTec Group PLC have a product recall in the last two years?
Does ConvaTec Group PLC disclose incidents of discrimination?
Does ConvaTec Group PLC allow for Work Councils/Collective Agreements to be formed?
Has ConvaTec Group PLC issued a profit warning in the past 24 months?
Does ConvaTec Group PLC disclose parental leave metrics?
Does ConvaTec Group PLC disclose climate scenario or pathway analysis?
Does ConvaTec Group PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does ConvaTec Group PLC disclose the pay ratio of women to men?
Does ConvaTec Group PLC support suppliers with sustainability related research and development?
Does ConvaTec Group PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does ConvaTec Group PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is ConvaTec Group PLC involved in embryonic stem cell research?
Does ConvaTec Group PLC disclose GHG and Air Emissions intensity?
Does ConvaTec Group PLC disclose its waste policy?
Does ConvaTec Group PLC report according to TCFD requirements?
Does ConvaTec Group PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does ConvaTec Group PLC disclose energy use targets?
Does ConvaTec Group PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does ConvaTec Group PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for ConvaTec Group PLC
These potential risks are based on the size, segment and geographies of the company.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.